1. Home
  2. STRT vs FULC Comparison

STRT vs FULC Comparison

Compare STRT & FULC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo STRATTEC SECURITY CORPORATION

STRT

STRATTEC SECURITY CORPORATION

HOLD

Current Price

$81.74

Market Cap

345.3M

ML Signal

HOLD

Logo Fulcrum Therapeutics Inc.

FULC

Fulcrum Therapeutics Inc.

HOLD

Current Price

$3.86

Market Cap

285.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STRT
FULC
Founded
1908
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
345.3M
285.4M
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
STRT
FULC
Price
$81.74
$3.86
Analyst Decision
Hold
Buy
Analyst Count
1
8
Target Price
$93.00
$16.38
AVG Volume (30 Days)
73.5K
1.3M
Earning Date
05-07-2026
04-27-2026
Dividend Yield
N/A
N/A
EPS Growth
12.53
N/A
EPS
4.04
N/A
Revenue
$439,195,000.00
N/A
Revenue This Year
$4.22
N/A
Revenue Next Year
$2.04
N/A
P/E Ratio
$20.63
N/A
Revenue Growth
5.24
N/A
52 Week Low
$57.01
$2.83
52 Week High
$92.50
$15.74

Technical Indicators

Market Signals
Indicator
STRT
FULC
Relative Strength Index (RSI) 43.21 51.01
Support Level $72.94 $3.44
Resistance Level $84.46 $3.96
Average True Range (ATR) 3.46 0.14
MACD -0.96 0.03
Stochastic Oscillator 10.84 73.86

Price Performance

Historical Comparison
STRT
FULC

About STRT STRATTEC SECURITY CORPORATION

Strattec Security Corp designs develops, manufactures, and markets mechanical locks, electronically enhanced locks, and keys. It also produces ignition lock housings; and access control products, including latches, power sliding door systems, and door handles. Strattec ships products to customer locations in the United States, Canada, Mexico, Europe, South America, Korea, and China, and provides full-service aftermarket support. Strattec also supplies products for the heavy truck and recreational vehicle markets, as well as precision, die castings.

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases. Its product candidate, Pociredir, is an oral small molecule designed to induce fetal hemoglobin (HbF) and is in clinical development for sickle cell disease (SCD). The company completed dosing in the Phase 1b PIONEER trial evaluating pociredir in adults with SCD and reported clinical data showing clinically relevant HbF induction and improvements in markers of hemolysis and anemia. The company has also generated a pipeline of clinical-stage and pre-clinical programs targeting the root causes of rare genetic diseases.

Share on Social Networks: